File: '\\swfile\EmailIn\20260423 060138 Attachment 20260423 - 04 FRE Appoints Dr. Arpit Bansal as Wellness Advisor.docx'

FOR IMMEDIATE RELEASE

FREQUENCY EXCHANGE CORP. APPOINTS

DR. ARPIT BANSAL AS A WELLNESS ADVISOR

VANCOUVER, BRITISH COLUMBIA - April 23, 2026 - Frequency Exchange Corp. (TSXV: FREQ) (OTC: FRECF) (FSE:YC6) ("Frequency" or the "Company") is pleased to announce the appointment of Dr. Arpit Bansal as a wellness advisor to the Company.

Dr. Bansal joins the Company's advisory group, which includes Dr. Leigh Erin Connealy, Dr. Tracey Stroup, and Dr. Milton Dowty. In his role as a wellness advisor, Dr. Bansal will support Frequency's efforts related to practitioner engagement, education initiatives, and international market development.

Dr. Bansal is a physician based in India with experience in clinical practice and public health engagement. He is also an active speaker at international health and wellness conferences and has participated in educational forums across multiple regions. The Company expects that his involvement will support ongoing engagement with practitioners and wellness communities in international markets.

Dr. Bansal will assist the Company in evaluating opportunities to introduce the NIKKI platform in India through practitioner networks and wellness-focused channels. He will also represent the Company at select conferences and industry events. In addition, Dr. Bansal has entered into an affiliate relationship with the Company.

"We are pleased to welcome Dr. Bansal to our advisory group," said Stephen Davis, Chief Executive Officer of Frequency Exchange Corp. "His experience in clinical practice and international speaking aligns with our focus on expanding practitioner engagement and advancing our presence in key global markets, including India. His involvement supports our ongoing efforts to build awareness and evaluate opportunities for the NIKKI platform across new regions."

Dr. Arpit Bansal commented, "I am pleased to join Frequency as a wellness advisor and to support its efforts to engage with practitioners and wellness communities internationally. I look forward to contributing to education and awareness initiatives as the Company evaluates opportunities in new markets, including India."

The Company notes that advisory roles are non-executive in nature and do not involve day-to-day operational responsibilities.

About Frequency Exchange Corp.

Frequency Exchange Corp. is the parent company of FREmedica Technologies Inc., a technology company focused on frequency-based digital wellness solutions designed to support cellular communication and broader wellness applications.

Originally developed with applications related to Lyme disease, the NIKKI platform has evolved into a wellness solution addressing sleep, stress, recovery, and performance - areas of increasing demand in international markets, including the Middle East. The Company's technology is supported by ongoing testing and quality-of-life evaluations.

More information is available at:

www.FrequencyExchangeCorp.com

www.WeAreNikki.com.

Investor Contacts

Frequency Exchange Corp. FREmedica Technologies Inc.

Stephen Davis Nicole Sullivan

CEO President

Stephen@frequencyexchangecorp.com Nicole.sullivan@wearenikki.com

Disclaimer for Forward-Looking Information

This news release includes certain forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation including the proposed Private Placement and use of proceeds. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking information or statements. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company can give no assurance that they will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Forward-looking information in this news release includes statements concerning the Company's general business plans. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Factors that could materially affect such forward-looking information are described in the risk factors in the Final Prospectus, and the schedules attached thereto, that are available on the Company's profile on SEDAR+ at www.sedarplus.ca.

Readers are cautioned that the foregoing list of factors is not exhaustive. The forward-looking statements included in this news release are expressly qualified by this cautionary statement. The forward-looking statements and information contained in this news release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.